Artal Group’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-450,000
| Closed | -$248K | – | 121 |
|
|
2023
Q4 | $248K | Hold |
450,000
| – | – | 0.01% | 87 |
|
|
2023
Q3 | $950K | Hold |
450,000
| – | – | 0.04% | 75 |
|
|
2023
Q2 | $1.18M | Hold |
450,000
| – | – | 0.04% | 83 |
|
|
2023
Q1 | $1.43M | Hold |
450,000
| – | – | 0.08% | 86 |
|
|
2022
Q4 | $1.21M | Hold |
450,000
| – | – | 0.07% | 98 |
|
|
2022
Q3 | $1.31M | Hold |
450,000
| – | – | 0.06% | 99 |
|
|
2022
Q2 | $1.31M | Hold |
450,000
| – | – | 0.07% | 109 |
|
|
2022
Q1 | $3.18M | Hold |
450,000
| – | – | 0.13% | 98 |
|
|
2021
Q4 | $7.2M | Buy |
+450,000
| New | +$7.2M | 0.2% | 79 |
|